News and Publications

CAP Articles - 2019 Block 1

Head/Neck

  • Ellis A, et al. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen–induced allergic rhinoconjunctivitis in an environmental exposure unit. Annals
  • Bachert C, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. JACI
  • Chang E, et al. Early life risk factors for chronic sinusitis: A longitudinal birth cohort study. JACI

Dermatologic

  • Hamad A, Jithpratuck W, Krishnaswamy G. Urticarial vasculitis and associated disorders. Annals
  • Czarnowicki T, et al. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. JACI
  • Yosipovitch G, et al. Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial. JAAD

Lung

  • Dicker A, et al. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease. JACI
  • Mukherjee M, et al. Sputum autoantibodies in patients with severe eosinophilic asthma. JACI
  • Desai M, Oppenheimer J, Tashkin D. Asthma-chronic obstructive pulmonary disease overlap syndrome What we know and what we need to find out. Annals

Food/Drug

  • Santos A, Brough H. Making the Most of In Vitro Tests to Diagnose Food Allergy. JACI in Practice
  • Sampson H, et al. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity. JAMA
  • Ierodiakonou D, et al. Timing of Allergenic Food Introduction to the Infant Diet and Risk of Allergic or Autoimmune Disease. JAMA

Anaphylaxis

  • Lieberman P, et al. Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics. JACI
  • Lee S, et al. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study. JACI
  • Buka R, et al. Anaphylaxis and Clinical Utility of Real-World Measurement of Acute Serum Tryptase in UK Emergency Departments. JACI

Hypersensitivity Disorders

  • Steri M, et al. Overexpression of the Cytokine BAFF and Autoimmunity Risk. NEJM
  • Cunningham A.L., et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. NEJM
  • Johnson D, et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. NEJM

Immunodeficiencies

  • Banerji A, et al. Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. NEJM
  • Monach P, et al. Case 6-2017: A 57-Year-Old Woman with Fatigue, Sweats, Weight Loss, Headache, and Skin Lesions. NEJM
  • De la Morena MT, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. JACI

Eos/Gastro

  • O'Sullivan J, Bochner B. Eosinophils and eosinophil-associated diseases: An update. JACI
  • Spergel J, Aceves S. Allergic components of eosinophilic esophagitis. JACI
  • Kuang F, Klion A. Biologic Agents for the Treatment of Hypereosinophilic Syndromes. JACI in Practice


Prior Blocks

  • CAP Articles - 2018 Block 2

    Head/Neck

    • Campbell AP, et al. Depression symptoms and lost productivity in chronic rhinosinusitis. Annals
    • Hui JW, et al. Risk of obstructive sleep apnea in African American patients with chronic rhinosinusitis. Annals
    • Stevens WW, et al. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. JACI in Practice

    Dermatologic

    • Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease). JACI
    • Fonacier L. A Practical Guide to Patch Testing. JACI in Practice
    • Paller AS, Kabashima K, Bieber T. Therapeutic pipeline for atopic dermatitis: End of the drought? JACI

    Lung

    • Corren J, et al. Tezepelumab in Adults with Uncontrolled Asthma. NEJM
    • Guilbert TW, et al. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids. JACI in Practice
    • Nair P, et al. Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma. NEJM

    Food/Drug

    • Coop CA, Schapira RS, Freeman TM. Are ACE Inhibitors and Beta-blockers Dangerous in Patients at Risk for Anaphylaxis? JACI in Practice
    • Jones SM, Burks AW. Food Allergy. NEJM
    • Vickery BP, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. JACI

    Anaphylaxis

    • Castells, M. Diagnosis and management of anaphylaxis in precision medicine. JACI
    • Feldweg AM. Food-Dependent, Exercise-Induced Anaphylaxis: Diagnosis and Management in the Outpatient Setting. JACI in Practice
    • Motosue MS, et al. Risk factors for severe anaphylaxis in the United States. Annals

    Hypersensitivity Disorders

    • Allenspach E, Torgerson TR. Autoimmunity and Primary Immunodeficiency Disorders. J Clin Immunol
    • Andersen YMF, et al. Autoimmune diseases in adults with atopic dermatitis. JAAD
    • Kanneganti T-D. Inflammatory Bowel Disease and the NLRP3 Inflammasome. NEJM

    Immunodeficiencies

    • Sullivan KE, et al. Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies. J Clin Immunol
    • Walter JE, et al. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies. JACI in Practice
    • Wirsum C, et al. Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency. J Clin Immunol

    Eos/Gastro

    • Chen Y-YK, et al. Marked and persistent eosinophilia in the absence of clinical manifestations. JACI
    • Molina-Infante J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. JACI
    • Pannaraj PS, et al. Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome. JAMA Pediatrics
  • CAP Articles - 2018 Block 1

    Head/Neck

    • Li JT, et al. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report. JACI
    • Bachert, C. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis. JAMA
    • Berard A, et al. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. JACI

    Dermatologic

    • Nomura, T. Advances in Atopic Dermatitis. JACI
    • Fonacier L, et al. Contact Dermatitis: A Practice Parameter-Update 2015. JACI in Practice
    • Simpson EL, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. NEJM

    Lung

    • Virchow, et al. Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults with Allergic Rhinitis. JAMA
    • Berry, A. Biomarkers in asthmatic patients: Has their time come to direct treatment? JACI
    • Stokes, J. Characterization of asthma endotypes: Implications for therapy. Annals
    • Bowatte, G. Traffic-related air pollution exposure is associated with allergic sensitization, asthma, and poor lung function in middle age. JACI

    Food/Drug

    • Wood, RA. Food allergen immunotherapy: Current status and prospects for the future. JACI
    • Perkin MR, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. NEJM
    • Togias, Alkis. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases sponsored expert panel. Annals

    Anaphylaxis

    • Ingelfinger, Julie R. Mast Cells, Mastocytosis, and Related Disorders (figure 2). NEJM
    • Golden, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Annals
    • Lieberman, P., et al. Anaphylaxis – a practice parameter update 2015. Annals
    • De Schryver, S, et al. Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors. JACI

    Hypersensitivity Disorders

    • Her, M. Alterations in immune function with biologic therapies for autoimmune disease. JACI
    • Green, PHR. Celiac Disease. JACI
    • Hoffman, HM. The role of the inflammasome in patients with autoinflammatory diseases. JACI

    Immunodeficiencies

    • Dobbs, K. Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections. NEJM.
    • Higgins, E. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. JACI
    • Gudmundsdottir, Judith. Early thymectomy leads to premature immunologic ageing: An 18-year follow-up. JACI
    • Loffredo L, et al. Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections. Annals
    • Bonilla, FA. Practice parameter for the diagnosis and management of primary immunodeficiency. JACI

    Eos/Gastro

    • Erwin EA. IgE Antibody Detection and Component Analysis in Patients with Eosinophilic Esophagitis. JACI
    • Martin, LJ. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. JACI
    • Furuta, G. Eosinophilic Esophagitis. NEJM
    • Williams KW, et al. Hypereosinophilia in Children and Adults: a retrospective comparison. JACI in Practice
    • Blumenthal KG, et al. Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. JACI
    • Furuta, GT. Eosinophilic Esophagitis. NEJM